PDM, PROT, PIR, PIKE – Companies Focus On Consumers from PennyToBuck.com
– Proteonomix, Inc. (OTC.BB:PROT), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, announced today that Mr. Michael Cohen, Chairman and CEO, is scheduling a multi-city European road trip to create additional awareness of the Proteonomix, Inc. investment opportunity to institutional investors.
Scheduled for early October, Mr. Cohen will discuss with sophisticated investors the recent contract to establish a joint venture with a group of investors that will establish a new stem cell treatment and research facility in the United Arab Emirates (U.A.E.). In addition, Mr. Cohen will discuss the opportunity to set up additional joint ventures in other countries using the U.A.E. arrangement as a model.
“Proteonomix has made great strides recently,” stated Mr. Cohen, “and we have been contacted by several European entities that have requested additional information about our proprietary stem cell activities. In recognition of the interest in Europe and the potential for additional joint venture agreements in various European countries, we recognize that it is propitious to meet with a number of the European institutional investors both to educate them on the intrinsic value of Proteonomix shares and garner interest in strategic relationships.”
Proteonomix is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. Proteoderm, Inc. is a wholly owned subsidiary of Proteonomix that has recently opened Proteoderm’s retail web site, Proteoderm.com, and begun accepting pre-orders for Proteoderm’s anti-aging line of skin care products. StromaCel, Inc.’s goal is the development therapeutic modalities for the treatment of Cardiovascular Disease (CVD). StromaCel, Inc. is pursuing the licensing of other technologies for therapeutic use. National Stem Cell, Inc. is Proteonomix’s operating subsidiary. The Sperm Bank of New York, Inc. is a fully operational tissue bank. Proteonomix Regenerative Translational Medicine Institute, Inc. (“PRTMI”) intends to focus on the translation of promising research in stem cell biology and cellular therapy to clinical applications of regenerative medicine. Proteonomix intends to create and dedicate a subsidiary to each of Proteonomix’s technologies.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Piedmont Office Realty Trust, Inc. (NYSE:PDM) has been notified of an unsolicited tender offer by MacKenzie Patterson Fuller, LP (“MPF”) to purchase up to 2,000,000, 30,000 and 60,000 shares, respectively, of the Class B-3, Class B-2 and Class A common stock of Piedmont at a price of $14.50 per share. Piedmont is not in any way affiliated with MPF, and believes this offer is not in the best interests of Piedmont Office Realty Trust’s stockholders. The Board of Directors of Piedmont has carefully evaluated the terms of MPF’s offer and unanimously recommends that stockholders reject MPF’s offer and not tender their shares.
Piedmont has filed with the Securities and Exchange Commission (“SEC”) a Schedule 14D-9 providing a detailed response to MPF’s offer. Piedmont encourages stockholders to read the Schedule 14D-9 before making a decision regarding the offer. Stockholders may review and obtain copies of the Schedule 14D-9 and all amendments thereto free of charge at the SEC’s website at http://www.sec.gov and at Piedmont’s website at http://investor.piedmontreit.com.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Pier 1 Imports, Inc. (NYSE:PIR) today disclosed that Pier 1 Imports is participating in the 2010 Wells Fargo Securities Consumer Conference being held September 29-30th at the Crowne Plaza Times Square Manhattan, New York. Cary Turner, Executive Vice President and Chief Financial Officer, will make a presentation on Wednesday, September 29th during which he will provide a general update on Pier 1 Imports’ business. Pier 1 Imports, Inc. is the original global importer of imported decorative home furnishings and gifts.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Pike Electric Corporation (NYSE:PIKE), one of the nation’s leading energy solutions providers, and Symbion Power LLC have been awarded two major new energy contracts under the Millennium Challenge Compact (MCC) which was signed between the governments of the United States of America and the United Republic of Tanzania in 2008. These two contracts valued at nearly $65 million were awarded by the Millennium Challenge Account Tanzania (MCA-Tanzania). Together, the two firms will construct or expand approximately 1,000 miles of distribution lines in the regions of Mwanza, Tanga, Dodoma, Mbeya, and Iringa.
Ambassador Lenhardt, U.S. Ambassador to the United Republic of Tanzania, praised MCA-Tanzania and both companies, noting that the contract was awarded only after a vigorous, full and open international competition. J. Eric Pike, Chairman and CEO of Pike Electric Corporation said, “Pike Electric is pleased and honored to be a part of the electric infrastructure build out in Tanzania. It is our goal to train and employ Tanzanians in modern construction techniques to provide reliable power throughout this great country.”
Pike Electric and Symbion were already working collaboratively on a three separate projects in Tanzania valued at nearly $19 million. Collectively, Pike Electric and Symbion have been awarded nearly $84 million in distribution powerline projects including engineering, material procurement and construction. Construction on these projects will begin early in calendar 2011 and will continue for approximately two years.
Pike Electric is a leading provider of energy solutions to over 200 investor-owned, municipal and cooperative utilities in the United States. Pike Electric’s comprehensive services include siting, permitting, engineering design, installation, maintenance and repair of power delivery systems, including renewable energy projects.
*************************************************************
For FREE Daily Stock Alerts & Updates Signup At: http://pennytobuck.com/signup
*************************************************************
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyToBuck.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer ( http://pennytobuck.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyToBuck.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received twenty thousand dollars in cash and twenty thousand dollars in free trading share from a third party (Swiss Financial Report) for (30) days of advertisement services for Proteonomix, Inc. (PROT.OB).
Short URL: http://www.mynewspaperdirectory.com/?p=170
Posted by 
